HF
GH icon

HRT Financial’s Guardant Health GH Stock Holding History

HRT Financial’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-77,117
Closed -$7.88M – 4128
2025
Q4 		$7.88M Buy
77,117
+8,770
+13% +$785K 0.02% 552
2025
Q3 		$4.27M Buy
+68,347
New +$3.72M 0.02% 747
2025
Q1 		– Sell
-71,977
Closed -$2.2M – 2824
2024
Q4 		$2.2M Buy
71,977
+4,973
+7% +$140K 0.01% 700
2024
Q3 		$1.54M Buy
+67,004
New +$1.9M 0.01% 1002
2024
Q2 		– Sell
-11,361
Closed -$234K – 2512
2024
Q1 		$234K Buy
+11,361
New +$244K ﹤0.01% 1689
2023
Q4 		– Sell
-49,977
Closed -$1.48M – 2588
2023
Q3 		$1.48M Buy
+49,977
New +$1.76M 0.01% 768
2023
Q2 		– Sell
-57,657
Closed -$1.35M – 2742
2023
Q1 		$1.35M Buy
+57,657
New +$1.65M 0.02% 802
2022
Q4 		– Sell
-25,996
Closed -$1.4M – 2702
2022
Q3 		$1.4M Buy
+25,996
New +$1.33M 0.02% 750
2022
Q1 		– Sell
-26,033
Closed -$1.78M – 3366
2021
Q4 		$2.6M Buy
+26,033
New +$2.69M 0.02% 519
2021
Q3 		– Sell
-25,638
Closed -$3.18M – 3444
2021
Q2 		$3.18M Sell
25,638
-50,271
-66% -$6.76M 0.03% 431
2021
Q1 		$11.6M Sell
75,909
-7,046
-8% -$1.06M 0.12% 114
2020
Q4 		$10.7M Buy
+82,955
New +$9.54M 0.22% 79

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's GH Position: Q1 2026 in Review

HRT Financial sold out of Guardant Health (GH) in Q1 2026, closing a stake of 77,117 shares — an estimated $7.88M sold.

HRT Financial first reported a position in GH in Q4 2020 and held it in 12 quarters. The position peaked at $11.6M in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • HRT Financial reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 77,117 Guardant Health shares in Q1 2026, an estimated $7.88M.
  • HRT Financial first reported a position in Guardant Health in Q4 2020 and held it in 12 quarters.
  • HRT Financial's Guardant Health position peaked at $11.6M in Q1 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.